[1]
|
Aringer, M., Costenbader, K., Daikh, D., et al. (2019) 2019 European League against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 78, 1151-1159. https://doi.org/10.1136/annrheumdis-2018-214819
|
[2]
|
Aringer, M. (2020) Inflammatory Markers in Systemic Lupus Erythematosus. Journal of Autoimmunity, 110, Article ID: 102374. https://doi.org/10.1016/j.jaut.2019.102374
|
[3]
|
Fousert, E., Toes, R. and Desai, J. (2020) Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses. Cells, 9, Article 915. https://doi.org/10.3390/cells9040915
|
[4]
|
Lee, K.H., Kronbichler, A., Park, D.D., et al. (2017) Neutrophil Extra-cellular Traps (NETs) in Autoimmune Diseases: A Comprehensive Review. Autoimmunity Reviews, 16, 1160-1173. https://doi.org/10.1016/j.autrev.2017.09.012
|
[5]
|
Xiang, S., Zhang, J., Zhang, M., et al. (2022) Imbalance of Help-er T Cell Type 1, Helper T Cell Type 2 and Associated Cytokines in Patients with Systemic Lupus Erythematosus: A Meta-Analysis. Frontiers in Pharmacology, 13, Article 988512. https://doi.org/10.3389/fphar.2022.988512
|
[6]
|
Paredes, J.L., Fernandez-Ruiz, R. and Niewold, T.B. (2021) T Cells in Systemic Lupus Erythematosus. Rheumatic Disease Clinics, 47, 379-393. https://doi.org/10.1016/j.rdc.2021.04.005
|
[7]
|
Munoz-Urbano, M., Quintero-Gonzalez, D.C. and Vasquez, G. (2022) T Cell Metabolism and Possible Therapeutic Targets in Systemic Lupus Erythematosus: A Narrative Review. Immunopharmacology and Immunotoxicology, 44, 457-470. https://doi.org/10.1080/08923973.2022.2055568
|
[8]
|
Robinson, G.A., Wilkinson, M.G.L. and Wincup, C. (2021) The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus. Frontiers in Immunology, 12, Article 806560.
https://doi.org/10.3389/fimmu.2021.806560
|
[9]
|
You, X., Zhang, R., Shao, M., et al. (2020) Double Negative B Cell Is Associated with Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remis-sion. Frontiers in Medicine, 7, Article 85.
https://doi.org/10.3389/fmed.2020.00085
|
[10]
|
Wang, T., Mei, Y. and Li, Z. (2019) Research Progress on Regula-tory B Cells in Systemic Lupus Erythematosus. BioMed Research International, 2019, Article ID: 7948687. https://doi.org/10.1155/2019/7948687
|
[11]
|
Firizal, A.S., Sugianli, A.K. and Hamijoyo, L. (2020) Cut off Point of Neutrophil-to-Lymphocyte Ratio as a Marker of Active Disease in Systemic Lupus Erythematosus. Lupus, 29, 1566-1570. https://doi.org/10.1177/0961203320950822
|
[12]
|
Li, Z., Xiao, Y. and Zhang, L. (2020) Application of Procalcitonin, White Blood Cell Count and Neutrophil-to-Lymphocyte Ratio in the Diagnosis of Systemic Lupus Ery-thematosus with a Bacterial Infection. Annals of Palliative Medicine, 9, 3870-3876. https://doi.org/10.21037/apm-20-1777
|
[13]
|
Ma, L., Zeng, A., Chen, B., et al. (2019) Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Systemic Lupus Erythematosus and Their Correlation with Activ-ity: A Meta-Analysis. International Immunopharmacology, 76, Article ID: 105949. https://doi.org/10.1016/j.intimp.2019.105949
|
[14]
|
Jin, S.Y., Yu, C.C. and Yu, B.W. (2021) Changes of Serum IL-6, IL-10 and TNF-α Levels in Patients with Systemic Lupus Erythematosus and Their Clinical Value. American Journal of Translational Research, 13, 2867-2874.
|
[15]
|
Xiang, M., Feng, Y., Wang, Y., et al. (2021) Correlation be-tween Circulating Interleukin-18 Level and Systemic Lupus Erythematosus: A Meta-Analysis. Scientific Reports, 11, Ar-ticle No. 4707.
https://doi.org/10.1038/s41598-021-84170-4
|
[16]
|
Liang, R., Zheng, L., Ji, T., et al. (2022) Elevated Serum Free IL-18 in Neuropsychiatric Systemic Lupus Erythematosus Patients with Seizure Disorders. Lupus, 31, 187-193. https://doi.org/10.1177/09612033211069853
|
[17]
|
Liu, W., Zhang, S. and Wang, J. (2022) IFN-γ, Should Not Be Ignored in SLE. Frontiers in Immunology, 13, Article 954706. https://doi.org/10.3389/fimmu.2022.954706
|
[18]
|
Oke, V., Gunnarsson, I., Dorschner, J., et al. (2019) High Levels of Circulating Interferons Type I, Type II and Type III Associate with Distinct Clinical Features of Active Systemic Lu-pus Erythematosus. Arthritis Research & Therapy, 21, Article No. 107. https://doi.org/10.1186/s13075-019-1878-y
|
[19]
|
Ghafouri-Fard, S., Shahir, M., Taheri, M. and Salimi, A. (2021) A Review on the Role of Chemokines in the Pathogenesis of Systemic Lupus Erythematosus. Cytokine, 146, Article ID: 155640. https://doi.org/10.1016/j.cyto.2021.155640
|
[20]
|
Ayano, M. and Horiuchi, T. (2023) Complement as a Biomarker for Systemic Lupus Erythematosus. Biomolecules, 13, Article 367. https://doi.org/10.3390/biom13020367
|
[21]
|
Weinstein, A., Alexander, R.V. and Zack, D.J. (2021) A Review of Complement Activation in SLE. Current Rheumatology Reports, 23, Article No. 16. https://doi.org/10.1007/s11926-021-00984-1
|
[22]
|
El-Serougy, E., Zayed, H., Ibrahim, N.M. and Maged, L.A. (2019) Procalcitonin and C-Reactive Protein as Markers of Infection in Systemic Lupus Erythematosus: The Controversy Continues. Lupus, 28, 1329-1336.
https://doi.org/10.1177/0961203318777101
|
[23]
|
Littlejohn, E., Marder, W., Lewis, E., et al. (2018) The Ratio of Erythrocyte Sedimentation Rate to C-Reactive Protein Is Useful in Distinguishing Infection from Flare in Systemic Lupus Erythematosus Patients Presenting with Fever. Lupus, 27, 1123-1129. https://doi.org/10.1177/0961203318763732
|
[24]
|
Wang, C.M., Deng, J.H., Mao, G.F., et al. (2020) Serum Amy-loid A: A Potential Biomarker Assessing Disease Activity in Systemic Lupus Erythematosus. Medical Science Monitor, 26, e923290. https://doi.org/10.12659/MSM.923290
|
[25]
|
Zhao, L., Zhang, Q., Feng, Z., et al. (2022) Serum Am-yloid A-to-Albumin Ratio as a Potential Biomarker to Predict the Activity, Severity, and Poor Prognosis of Systemic Lupus Erythematosus. Journal of Clinical Laboratory Analysis, 36, e24282. https://doi.org/10.1002/jcla.24282
|
[26]
|
Sumova, B., Cerezo, L.A., Szczukova, L., et al. (2019) Circulating S100 Proteins Effectively Discriminate SLE Patients from Healthy Controls: A Cross-Sectional Study. Rheumatology Interna-tional, 39, 469-478.
https://doi.org/10.1007/s00296-018-4190-2
|
[27]
|
Tydén, H., Lood, C., Gullstrand, B., et al. (2017) Pro-Inflammatory S100 Proteins Are Associated with Glomerulonephritis and Anti-dsDNA Antibodies in Systemic Lu-pus Erythematosus. Lupus, 26, 139-149.
https://doi.org/10.1177/0961203316655208
|
[28]
|
Kim, J.W., Jung, J.Y., Lee, S.W., et al. (2022) S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus. Frontiers in Immunology, 13, Article 886209. https://doi.org/10.3389/fimmu.2022.886209
|
[29]
|
Wang, J., Niu, R., Jiang, L., et al. (2019) The Diagnostic Values of C-Reactive Protein and Procalcitonin in Identifying Systemic Lupus Erythematosus Infection and Disease Ac-tivity. Medicine, 98, e16798.
https://doi.org/10.1097/MD.0000000000016798
|